Proteon Therapeutics Initiates Patient Enrollment in Phase 1 Clinical Study of PRT-201 in Patients Suffering from Peripheral Art

Proteon Therapeutics announced that it has begun enrollment in its Phase 1 clinical trial to treat patients with peripheral arte... [more]

View complete Press Release article